Obstetrics & Gynecology · Ocala, FL
NPI
1912929332
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
150 SE 17th St Ste 400
Ocala, FL, 34471
Phone (352) 622-9226
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,003
69 services
Medicare patients, 2024
21
Average age 64
Drug cost, 2024
$7,022
52 prescriptions
Company payments, 2024
$29.29
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rasiklal D Nagda was code 99213 (office e&m - established), 20 times for 11 patients. In total Rasiklal D Nagda billed 69 services in 8 codes, and Medicare paid $3,003.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 20 | 11 | $52.79 | $1,056 |
| 82270 Immunoassay | Office | 14 | 14 | $4.29 | $60.06 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 14 | 14 | $41.66 | $583 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 11 | 11 | $38.10 | $419 |
By year: 2022 $9,071 for 103 services; 2023 $3,657 for 81 services; 2024 $3,003 for 69 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 14 | 14 | $4.29 | $60.06 |
Medicare prescription drug claims, 2024
In 2024, the drug Rasiklal D Nagda prescribed most often to Medicare patients was Prempro (Estrogen,con/M-Progest Acet), with 13 prescriptions and refills. In total Rasiklal D Nagda wrote 52 Medicare prescriptions that cost $7,022.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prempro Estrogen,con/M-Progest Acet | 13 | 13 | Under 11 | $3,213 |
| Tri-Estarylla Norgestimate-Ethinyl Estradiol | 12 | 12 | Under 11 | $240 |
Brand drugs: 20 claims; generic drugs: 32 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Rasiklal D Nagda $29.29 ($29.29 in general payments such as food, travel and fees) from 1 company. The largest payer was 3B Medical, Inc. with $29.29.
| Company | Payments | Amount |
|---|---|---|
| 3B Medical, Inc. | 1 | $29.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.